Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FFBT0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $200,310
Award facts
- Contract value 100% obligated
- $200,309.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $200,309.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, issued on December 26, 2025, with an ultimate completion date of December 29, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was funded by the Defense Logistics Agency and represents performance under the broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract under the PPV-G GEN V umbrella contract (SPE2DR), which was awarded on November 13, 2025, with a $499.99 billion ceiling value and completion date of December 31, 2036. This master contract positions the company as a critical regional pharmaceutical supplier for the Department of Defense, authorized to provide branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support military healthcare facilities worldwide. The broader PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to establish multiple prime vendor contractors capable of fulfilling the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FFBT0?
SPE2DR26FFBT0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DR26FFBT0 worth?
The government has obligated $200,310 on SPE2DR26FFBT0.
Is contract SPE2DR26FFBT0 an order under another contract?
Yes. SPE2DR26FFBT0 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBT0 competed?
The extent of competition for SPE2DR26FFBT0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award